These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38587846)

  • 21. Intravesical hyaluronic acid and alkalinized lidocaine for the treatment of severe painful bladder syndrome/interstitial cystitis.
    Lv YS; Zhou HL; Mao HP; Gao R; Wang YD; Xue XY
    Int Urogynecol J; 2012 Dec; 23(12):1715-20. PubMed ID: 22576327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
    Tutolo M; Ammirati E; Castagna G; Klockaerts K; Plancke H; Ost D; Van der Aa F; De Ridder D
    Int Braz J Urol; 2017; 43(1):134-141. PubMed ID: 28124536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravesical treatments for painful bladder syndrome/ interstitial cystitis.
    Dawson TE; Jamison J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD006113. PubMed ID: 17943887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
    Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
    Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
    Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
    Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis.
    Morales A; Emerson L; Nickel JC; Lundie M
    J Urol; 1996 Jul; 156(1):45-8. PubMed ID: 8648835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of pain and quality of life after hyaluronic acid instillation in addition to botulinum toxin-A injection in women with refractory Interstitial Cystitis/Painful Bladder Syndrome: A pilot study.
    Ghaith AF; Radwan MH; Rashed Taha M; Elbendary MA; Al Damhogy ME; Hagras AM
    Arch Ital Urol Androl; 2022 Dec; 94(4):447-450. PubMed ID: 36576459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical comparision of intravesical hyaluronic acid and hyaluronic acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis.
    Gülpınar O; Kayış A; Süer E; Gökçe Mİ; Güçlü AG; Arıkan N
    Can Urol Assoc J; 2014 Sep; 8(9-10):E610-4. PubMed ID: 25295131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
    Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
    Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the Clinical Efficacy and Adverse Events between Intravesical Injections of Platelet-Rich Plasma and Botulinum Toxin A for the Treatment of Interstitial Cystitis Refractory to Conventional Treatment.
    Jhang JF; Yu WR; Kuo HC
    Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Jhang JF; Lin TY; Kuo HC
    Neurourol Urodyn; 2019 Feb; 38(2):703-709. PubMed ID: 30576011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis.
    Shao Y; Shen ZJ; Rui WB; Zhou WL
    Urology; 2010 Mar; 75(3):547-50. PubMed ID: 20022087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review.
    Han XM; Wu XH; Li B; Pan F; Li WC; Liu SL; Zeng FQ; Chen M
    Taiwan J Obstet Gynecol; 2015 Jun; 54(3):240-7. PubMed ID: 26166334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bladder Instillations With Triamcinolone Acetonide for Interstitial Cystitis-Bladder Pain Syndrome: A Randomized Controlled Trial.
    Cardenas-Trowers OO; Abraham AG; Dotson TK; Houlette BA; Gaskins JT; Francis SL
    Obstet Gynecol; 2021 May; 137(5):810-819. PubMed ID: 33831942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and Feasibility of Intravesical Instillation of Botulinum Toxin-A in Hydrogel-based Slow-release Delivery System in Patients With Interstitial Cystitis-Bladder Pain Syndrome: A Pilot Study.
    Rappaport YH; Zisman A; Jeshurun-Gutshtat M; Gerassi T; Hakim G; Vinshtok Y; Stav K
    Urology; 2018 Apr; 114():60-65. PubMed ID: 29307733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome/interstitial cystitis.
    Barua JM; Arance I; Angulo JC; Riedl CR
    Int Urogynecol J; 2016 Aug; 27(8):1137-47. PubMed ID: 26590137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis.
    Cervigni M; Natale F; Nasta L; Padoa A; Voi RL; Porru D
    Int Urogynecol J Pelvic Floor Dysfunct; 2008 Jul; 19(7):943-7. PubMed ID: 18338095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial.
    Ko KJ; Cho WJ; Lee YS; Choi J; Byun HJ; Lee KS
    Eur Urol; 2020 May; 77(5):644-651. PubMed ID: 31959549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.